Gene · 2072
Papers3,434
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
621 to 640 of 3,434
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Molecular Mechanisms of Cancer Drug Resistance: Emerging Biomarkers and Promising Targets to Overcome Tumor Progression. | Cancers (Basel) | 2022 | 35406386 | PubTator, text mining | PubMed |
| Retinoids in the Pathogenesis and Treatment of Liver Diseases. | Nutrients | 2022 | 35406069 | PubTator, text mining | PubMed |
| Xeroderma Pigmentosum-Associated Childhood Interstitial Lung Disease. | Turk Thorac J | 2022 | 35404252 | PubTator, text mining | PubMed |
| UV Irradiation of Vaccinia Virus-Infected Cells Impairs Cellular Functions, Introduces Lesions into the Viral Genome, and Uncovers Repair Capabilities for the Viral Replication Machinery. | J Virol | 2022 | 35404095 | PubTator, text mining | PubMed |
| EGFR-RAD51 gene fusion NSCLC responsiveness to different generation EGFR-TKIs: two cases and review of the literature. | Transl Lung Cancer Res | 2022 | 35399574 | PubTator, text mining | PubMed |
| DNA Repair Protein HELQ and XAB2 as Chemoresponse and Prognosis Biomarkers in Ascites Tumor Cells of High-Grade Serous Ovarian Cancer. | J Oncol | 2022 | 35392433 | PubTator, text mining | PubMed |
| [Research progress of Fanconi anemia and DNA interstrand crosslink repair]. | Zhonghua Xue Ye Xue Za Zhi | 2022 | 35381685 | PubTator, text mining | PubMed |
| Modulation of ERCC1-XPF Heterodimerization Inhibition via Structural Modification of Small Molecule Inhibitor Side-Chains. | Front Oncol | 2022 | 35372043 | PubTator, text mining | PubMed |
| Biomarkers of Chemotherapy-Induced Peripheral Neuropathy: Current Status and Future Directions. | Front Pain Res (Lausanne) | 2022 | 35360655 | PubTator, text mining | PubMed |
| Non-Melanoma Skin Cancers and Other Cutaneous Manifestations in Bone Marrow Failure Syndromes and Rare DNA Repair Disorders. | Front Oncol | 2022 | 35359366 | PubTator, text mining | PubMed |
| Helicobacter pylori-induced DNA double-stranded break in the development of gastric cancer. | Cancer Sci | 2022 | 35359025 | PubTator, text mining | PubMed |
| TREX1 degrades the 3' end of the small DNA oligonucleotide products of nucleotide excision repair in human cells. | Nucleic Acids Res | 2022 | 35357486 | PubTator, text mining | PubMed |
| Lessons From Pediatric MDS: Approaches to Germline Predisposition to Hematologic Malignancies. | Front Oncol | 2022 | 35356204 | PubTator, text mining | PubMed |
| Fanconi Anemia Pathway in Colorectal Cancer: A Novel Opportunity for Diagnosis, Prognosis and Therapy. | J Pers Med | 2022 | 35330396 | PubTator, text mining | PubMed |
| Targeting DNA Damage Response and Immune Checkpoint for Anticancer Therapy. | Int J Mol Sci | 2022 | 35328658 | PubTator, text mining | PubMed |
| Optimized Protocol for Proportionate CNS Cell Retrieval as a Versatile Platform for Cellular and Molecular Phenomapping in Aging and Neurodegeneration. | Int J Mol Sci | 2022 | 35328432 | PubTator, text mining | PubMed |
| Identification of Frameshift Variants in POLH Gene Causing Xeroderma Pigmentosum in Two Consanguineous Pakistani Families. | Genes (Basel) | 2022 | 35328096 | PubTator, text mining | PubMed |
| Targeting DNA polymerase to DNA double-strand breaks reduces DNA deletion size and increases templated insertions generated by CRISPR/Cas9. | Nucleic Acids Res | 2022 | 35323942 | PubTator, text mining | PubMed |
| Cancer Predisposition Genes in Adolescents and Young Adults (AYAs): a Review Paper from the Italian AYA Working Group. | Curr Oncol Rep | 2022 | 35320498 | PubTator, text mining | PubMed |
| DNA repair defects in cancer and therapeutic opportunities. | Genes Dev | 2022 | 35318271 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2072/papers?page=32